Onychodystrophy associated with dupilumab therapy for atopic dermatitis

Onychodystrophy associated with dupilumab therapy for atopic dermatitis

Bibliographic Details
Main Authors:	Amanda E. Zubek, MD, PhD, Matthew D. Vesely, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	JAAD Case Reports
Subjects:	atopic dermatitis dupilumab eczematous nails nail dystrophy onychodystrophy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512620307657

Similar Items

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021-05-01)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021-04-01)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018-03-01)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020-05-01)

Dupilumab side effect in a patient with atopic dermatitis: a case report study
by: Albader SS, et al.
Published: (2019-05-01)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021-01-01)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
by: Yolanka Lobo, et al.
Published: (2021-05-01)

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020-10-01)

Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis
by: Emilie Fowler, et al.
Published: (2019-06-01)

Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
by: Adrien Mareschal, et al.
Published: (2020-01-01)

Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis
by: Gavin Li, et al.
Published: (2020-09-01)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020-02-01)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
by: Ceryn J, et al.
Published: (2021-08-01)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2020-07-01)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
by: Chia-Jui Su, MD, et al.
Published: (2021-05-01)

Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab
by: Caroline Meyer Olesen, et al.
Published: (2021-07-01)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020-12-01)

Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
by: D’Erme AM, et al.
Published: (2017-05-01)

Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
by: Lina U. Ivert, et al.
Published: (2019-02-01)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
by: Surina Frey, et al.
Published: (2021-03-01)

Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
by: Jorge R. Georgakopoulos, MD, et al.
Published: (2021-09-01)

Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab
by: Diana Gruenstein, BA, et al.
Published: (2020-12-01)

Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis
by: Awosika O, et al.
Published: (2018-01-01)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
by: Leah Laageide, MD, et al.
Published: (2021-09-01)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020-11-01)

Novel topical and systemic therapies in atopic dermatitis
by: Hiraku Suga, et al.
Published: (2019-04-01)

Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis
by: Tamara Quint, et al.
Published: (2020-04-01)

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
by: Simona Tavecchio, et al.
Published: (2020-08-01)

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
by: Helen He, et al.
Published: (2020-08-01)

Transient Increase in Circulating Basophils and Eosinophils in Dupilumab-associated Conjunctivitis in Patients with Atopic Dermatitis
by: Michie Katsuta, et al.
Published: (2021-06-01)

Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience
by: Silvia Ferrucci, et al.
Published: (2020-03-01)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
by: Adrien Maudinet, et al.
Published: (2019-06-01)

Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
by: Vingopoulos F, et al.
Published: (2020-07-01)

Dupilumab Treatment in Atopic Dermatitis: Real-World Evidence from a Portuguese Tertiary Center
by: Tomás Pessoa e Costa, et al.
Published: (2021-06-01)

Microscopic Examination of Nail Clippings from Patients with Palmoplantar Pustulosis
by: Anber Ancel Tanaka, et al.
Published: (2019-10-01)

Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study
by: Sandipan Dhar, et al.
Published: (2021-01-01)

Case Report of a Pilot with Atopic Dermatitis
by: Young Hwan Kwon
Published: (2021-08-01)

Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results
by: Servando E. Marron, et al.
Published: (2021-06-01)

Ophiasis treated with dupilumab
by: McKenna Abercrombie, DO, et al.
Published: (2021-10-01)

De novo case of lichenoid eruption following dupilumab treatment
by: Tae-Eun Kim, MD, et al.
Published: (2021-07-01)